| Serial Number | 97506782 |
| Word Mark | NANOVATIONTX |
| Filing Date | Sunday, July 17, 2022 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, October 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging |
| Pseudo Mark | NANOVATION TX |
| Goods and Services | Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 8, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 1, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NanoVation Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | British Columbia V6T1Z3 CA |
| Event Date | Event Description |
| Wednesday, July 20, 2022 | NEW APPLICATION ENTERED |
| Monday, August 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, May 2, 2023 | ASSIGNED TO EXAMINER |
| Thursday, June 1, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, June 1, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, June 1, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 1, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, June 1, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, June 1, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 31, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 31, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 1, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 2, 2023 | SUSPENSION LETTER WRITTEN |
| Monday, October 2, 2023 | LETTER OF SUSPENSION E-MAILED |
| Monday, October 2, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, April 5, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, June 10, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, October 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 2, 2024 | ASSIGNED TO LIE |
| Wednesday, April 10, 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, April 10, 2024 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, April 10, 2024 | INQUIRY TO SUSPENSION E-MAILED |